Medicamen Biotech Net Profit Surges 95% YoY to ₹4.1 Crore in Q2 FY27
Medicamen Biotech reports a 95.2% YoY increase in net profit to ₹4.1 crore for Q2 FY27, with operating margins expanding to 9.3% as revenue hits ₹54.8 crore.
ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →